Intestinal Fatty Acid Binding Protein (I-FABP) in Patients with Inflammatory Bowel Diseases with and without MAFLD

Intestinal Fatty-Acid-Binding Protein in Neonatal Necrotizing Enterocolitis

Role of Intestinal Ultrasonography in Assessment of Disease Activity in Ulcerative Colitis Patients

Study of Intestinal Fatty Acid Binding Protein-2 in Cirrhotic Patients and its Relation to Chronic Use of Proton Pump Inhibitors in Decompensated Cirrhosis

Role of Fatty Acid Binding Protein 1 in Non- Alcoholic Fatty Pancreatic Disease with and without Diabetes Mellitus

THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS

Nutritional Assessment in Patients with Inflammatory Bowel Disease

Human Intestinal Fatty Acid Binding Protein as a Prognostic Marker in Premature Neonates Suffering from Necrotizing Enterocolitis

Fecal Lactoferrin as a New Marker of Disease Activity in Inflammatory Bowel Diseases

THE ROLE OF SERUM VISFATIN IN THE DIAGNOSIS OF ACTIVE INFLAMMATORY BOWEL DISEASE